Scientists at the Gamaleya Center have discovered antibodies to the omicron in those revaccinated with Sputnik V
Photo: Pavel Lisitsyn / RIA Novosti
Specialists from the Russian Gamaleya Center found that all tested samples revaccinated with the Sputnik V vaccine developed antibodies to the omicron strain of coronavirus. This was reported on the Twitter account of the Russian vaccine, citing a study by the center.
“Moreover, the level of neutralizing antibodies to omicron in the sera of revaccinated persons is slightly higher than the level of antibodies to the original strain of coronavirus (B.1.1.1.) In the sera of vaccinated persons,” the scientists said.
Earlier, the head of the Gamaleya Center, Alexander Gintsburg, said that vaccination with the Russian drug against the Sputnik V coronavirus can be carried out every six months an infinite number of times. He also noted that today “Sputnik V” does not need to update the vaccine strain and specified.
A new strain of coronavirus, code B.1.1.529, was identified in South Africa on November 11. The first confirmed cases of infection date from November 24. The strain was named with the Greek letter “omicron” and has already managed to recognize its danger at the level of the World Health Organization.
